Laddar...
Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy
OBJECTIVE: To provide the first clinical report that 2 calcitonin gene-related peptide (CGRP) therapies, a small molecule CGRP receptor antagonist and an anti-CGRP receptor antibody, can be used concomitantly to treat refractory migraine. METHODS: Case reports are presented of 2 patients participati...
Sparad:
| I publikationen: | Neurology |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Lippincott Williams & Wilkins
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7526667/ https://ncbi.nlm.nih.gov/pubmed/31932515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000008944 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|